Archived Press Releases
Wednesday, June 9, 2010
REDMOND, June 9, 2010, Medical device marketing and regulatory professionals, are you aware of the revisions to the European Union Medical Device Directive (“EU MDD”) that took effect March 21, 2010? Are you in compliance?
All medical devices bearing the CE mark must comply with the essential requirements established in Annex I of the MDD, ensuring, among other things, that they do not compromise the health and safety of patients, users and any other person and that they perform as intended by the manufacturer. more ...
Wednesday, March 17, 2010
SAN FRANCISCO, March 17, 2010, MedIntelliBase / The Next Phase, Inc. has been selected for the 2009 Best of Business Award in the Market Intelligence Services category by the Small Business Commerce Association (SBCA) The Small Business Commerce Association (SBCA) is pleased to announce that MedIntelliBase / The Next Phase, Inc. has been selected for the 2009 Best of Business Award in the Market Intelligence Services category more ...
Friday, November 6, 2009
REDMOND, Wash.--(BUSINESS WIRE)--Visitors to the newly branded and redesigned website of the Washington Biotechnology & Biomedical Association (WBBA) to be featured at the WBBA’s Annual Meeting today will get free, timely, Washington state-focused biotech and medtech news through its “Economic Issues in WA Healthcare” Breaking News feature. This new feature, powered by MedIntelliBase® Intelligence Services, provides a precisely focused RSS feed of economic, government more ...
Tuesday, June 10, 2008
SAN DIEGO, CA—June 10, 2008 — BIOTECHNOLOGY INTERNATIONAL ORGANIZATION (BIO) INTERNATIONAL CONVENTION 2008—Busy medical industry executives who have a critical need for timely market intelligence now have two smarter alternatives. At BIO2008, The Next Phase, Inc. will show how MedIntelliBase® Custom Alerts and MedIntelliBase Custom MarketTracks™ Databases help biotech, medical device and pharmaceutical companies gain and sustain a competitive advantage and... Read More...
Tuesday, May 6, 2008
REDMOND, Wash.--(BUSINESS WIRE)--Visitors to ResuscitationCentral.com can get free weekly clinical resuscitation abstracts through its Breaking News page. The Breaking News feature, powered by MedIntelliBase Custom Alerts, provides a live RSS feed of valuable clinical resuscitation abstracts drawn from PubMed and other sources... Read More...
Friday, April 4, 2008
REDMOND, WA—April 24, 2008 — Medical industry executives who rely on timely market intelligence now have two smarter alternatives. MedIntelliBase ® Custom Alerts and MedIntelliBase Custom MarketTracks™ Databases help biotech, medical device and pharmaceutical companies gain and sustain a competitive advantage.
MIB Alerts and MarketTracks, MedIntelliBase Market Intelligence Tools, are two from a toolbox of many customized services. Fully hyperlinked, MedIntelliBase Tools instantly send the intelligence you need - whenever and wherever you are... Read More...
For the Business Wire edition of this press release, please click here.
Thursday, April 20, 2006
REDMOND, WA—April 20, 2006 — Users of traditional multi-client market research studies know their limitations: high price-to-information ratio, lots of filler, and limited or no search capability. The final injustice is realizing that the report was obsolete the moment you purchased it – as much as 12-18 months out of date; a huge disadvantage in this fast-changing industry.
MedIntelliBase MarketTracks offer “A Better Way.” MIB MarketTracks are easily searched - all information is in cross-linked online databases and is regularly updated. You can also access intelligence offline through downloadable reports - all for one subscription price...
Thursday, June 30, 2005
REDMOND, WA—June 30, 2005— MedIntelliBase, a new online service featuring the medical industry’s most extensive cardiovascular market research and an authoritative data storehouse on related technologies, products, trends and clinical research, has been launched by The Next Phase Publishing. Available by subscription, the inaugural track for MedIntelliBase investigates “Coronary Artery Revascularization: Developments and Trends in Restenosis Prevention and Treatment—Beyond Drug-Eluting Stents.”
"MedIntelliBase (MIB) is a comprehensive service that enables subscribers to quickly navigate a vast knowledgebase of medical intelligence anywhere, anytime..."